A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management

Current Controlled Trials in Cardiovascular Medicine

Volumn 5, Issue , 2004, Pages

  Morgan, John M ^a   Sterns, Laurence D ^b   Hanson, Jodi L ^c   Ousdigian, Kevin T ^c   Otterness, Mary F ^c   Wilkoff, Bruce L ^d  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b Victoria Heart Institute Foundation   (Canada)

^c MEDTRONIC INC   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Detection; Empiric; ICD; Implantable cardioverter defibrillator; Programming; Shocks; Therapy

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; ELECTRIC SHOCK; EMPIRICISM; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INDIVIDUALIZATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROCESS OPTIMIZATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STANDARDIZATION; TREATMENT PLANNING;

EID: 27544447928     PISSN: 14686694     EISSN: 14686694     Source Type: Journal    
DOI: 10.1186/1468-6708-5-12     Document Type: Review

References (22)

1. Dijkman B, Wellens HJ: Dual chamber arrhythmia detection in the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000, 11:1105-15.
2. Theuns D, Kloolwijk AP, Kimman GP, Szili-Torok T, Roelandt JR, Jordaens L: Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. Europace 2001, 3:181-6.
3. Wilkoff B, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg F, DeSouza C: Critical Analysis of Dual-Chamber ICD Arrhythmia Detection. Circulation 2001, 103:381-386.
4. Sears SF, Tocaro J, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, Curtis A, Conn J: Assessing the Psychosocial Impact of the ICD. PACE 2000, 23:1-6.
5. Schaumann A, Popping A, Fabian O: Efficacy of Antitachycardia Pacing in 180 Patients with a History of Ventricular Fibrillation. Circulation 1999, 100:1-571. AHA
6. Wathen M, Sweeney M, DeGroot P, Stark A, Koehler J, Chisner M, Machado D, Adkisson W: Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardias in Patients with Coronary Artery Disease. Circulation 2001, 104:796-801.
7. Schaumann A, Muhlen F, Herse B, Gonska B, Kreuzer H: Empirical Versus Tested Anti-tachycardia Pacing in Implantable Cardioverter Defibrillators. Circulation 1998, 97:66-74.
8. Connelly D, Cardinal D, Foley L, Corrigan S, Waters M, Lemery R, Steinhaus D: Is Routine Pre-Discharge Testing Necessary for Patients with Implantable Cardioverter-Defibrillators? PACE 1996, 19:196.
9. Fiek M, Hoffmann E, Dorwath U, Muller D, Steinbeck G: Long-term Efficacy of Anti-tachycardia Pacing for Treatment of Ventricular Tachycardia in Patients with Implantable Cardioverter/Defibrillators. Z Kardiol 1999, 88:815-822.
10. Wathen M, DeGroot P, Adkisson W, Machado C, Chisner M, Stark A, Koehler J: Can One Antitachycardia Pacing Regimen Work for All Ventricular Tachycardias? Circulation 2001, 104:11-772.
11. Monahan K, Hadjis T, Hallet N, Casavant D, Josephson M: Correlation of Induced to Spontaneous Ventricular Tachycardia from Analysis of Stored Far-Field Implantable Defibrillator Electrograms. Am J Cardiol 1999, 83:349-353.
12. Raitt M, Dolack L, Kudenchuk P, Poole J, Bardy G: Ventricular Arrhythmias Detected After Transvenous Defibrillator Implantation in Patients With a Clinical History of Only Ventricular Fibrillation. Circulation 1995, 91:1996-2001.
13. Exner D, Gillis A, Sheldon R, Wyse G, Duff H, Cassidy P, Mitcheli B: Telemetry-Documented, Pace-Terminable Ventricular Tachycardia in Patients with Ventricular Fibrillation. American Journal of Cardiology 1998, 81:235-238.
14. Ruppel R, Schluter C, Boczor S, Meinertz T, Schulter M, Kuck K, Cappato R: Ventricular Tachycardia During Follow-up in Patients Resuscitated From Ventricular Fibrillation: Experience From Stored Electrograms of Implantable Cardioverter-Defibrillators. JACC 1998, 32:1724-30.
15. Ousdigian K, Gillberg J, Koehler J, Stadler R, DeGroot P, Olson W, for the Worldwide GEM DR Investigators: How Often Is ICD-Detected VF Actually Monomorphic VT? PACE 2001, 24:731.
16. Gunderson B, Olson W, Brown T, Swerdlow C, and tne GEM DR Clinical Worldwide Investigators: Increasing the Number of Intervals for VF Detection Increases Implantable Cardioverter-Defibrillator Longevity. Circulation 2002, 106(19):11-322.
17. DeGroot P, Sharma V, Wathen M, Sweeney M, Chisner M, Machado C, Adkisson W, Koehler J, Stark A, and for the PainFREE Rx Investigators: Implantable Cardioverter Defibrillator Detected Ventricular Fibrillation with Cycle Length < 240 ms is Predeominantly Fast Monomorphic Tachycardia. PACE 2001, 24:722.
18. Gold M, Higgins S, Klein R, Gilliam R, Kopelman H, Hessen S, Payne J, Strickberger A, Breiter D, Hahn S: Efficacy and Temporal Stability of Reduced Safety Margins. Circulation 2002, 105:2043-2048.
19. Garcia-Moran E, Mont L, Matas C, Brugada J: Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator. Eur Heart J 2002, 23:901-907.
20. Medtronic Marquis DR Manual..
21. Wilkoff B, Gillberg J, DeSouza C: The Enhanced PR Logic Dual Chamber Tachyarrhythmia Detection Algorithm: Retrospective Analysis of Supraventricular Tachycardia With Long PR Intervals. JACC 2001:131A.
22. Bansch D, Castrucci M, Bocker D, Breithardt G, Block M: Ventricular Tachycardias Above the Initially Programmed Tachycardia Detection Interval in Patients with Implantable Cardioverter-Defibrillators. JACC 2000, 36:557-65.